In vivo treatment of susceptible Escherichia coli cultures with low concentrations of dihydrostreptomycin leads to a decline in polysomes and a corresponding increase in 70S particles which behave as run-off ribosomes, as well as free 30S and 50S subunits. We have examined the timing and extent of these effects on ribosomes and compared them to the effects of this antibiotic on growth and protein synthesis. We have shown that no changes in ribosome distribution are observed until growth inhibition by dihydrostreptomycin is almost complete. Thus, intracellular dihydrostreptomycin can inhibit growth and net protein synthesis without apparently affecting the ribosome cycle. Since it is known that the antibiotic combines with free 30S subunits, the question is how such combination can bring about the observed inhibition of protein synthesis and growth. We suggest that specific interaction of intracellular antibiotic with proteins of the 30S subunits allows repeated use of the ribosome cycle by such affected particles, but with selective misreading of certain amino acid codons as terminator codons, so that they produce incomplete polypeptide chains. The cumulative effect of such a mechanism would lead to eventual cessation of protein synthesis and growth.
In vivo treatment of susceptible Escherichia coli cultures with low concentrations of dihydrostreptomycin leads to a decline in polysomes and a corresponding increase in 70S particles which behave as run-off ribosomes, as well as free 30S and 50S subunits. We have examined the timing and extent of these effects on ribosomes and compared them to the effects of this antibiotic on growth and protein synthesis. We have shown that no changes in ribosome distribution are observed until growth inhibition by dihydrostreptomycin is almost complete. Thus, intracellular dihydrostreptomycin can inhibit growth and net protein synthesis without apparently affecting the ribosome cycle. Since it is known that the antibiotic combines with free 30S subunits, the question is how such combination can bring about the observed inhibition of protein synthesis and growth. We suggest that specific interaction of intracellular antibiotic with proteins of the 30S subunits allows repeated use of the ribosome cycle by such affected particles, but with selective misreading of certain amino acid codons as terminator codons, so that they produce incomplete polypeptide chains. The cumulative effect of such a mechanism would lead to eventual cessation of protein synthesis and growth.
A great deal is known about the interaction of streptomycin and dihydrostreptomycin with bacterial ribosomes (2, 3, 5, 7, 10, 14, 19, 30, 32, 40, 45, 46, 55, 60, 61) , but the mechanism by which these antibiotics bring about the cessation of protein synthesis in vivo is still unknown. To some extent this reflects the difficulties of studying the intracellular effects of a drug in vivo and the problems of interpreting in vitro observations. Recent development of lytic methods has allowed rapid release of ribosomal material from bacteria, under conditions which largely preserve their in vivo distribution (16, 27, 43, 51) . This permitted the study of effects of antibiotic treatment in vivo on the ribosome cycle of susceptible organisms (28, 32, 38, 40, 41, 42) . It was found that on streptomycin treatment polysomes declined and ribosomes sedimenting at 70S accumulated, but these observations have been variously interpreted. We feel that some confusion has arisen because the following points, essential for the interpretation of such effects, have not always been taken into consideration: the nature and measurement of the physiological effects of the antibiotic to which changes in ribosome patterns are to be related; the uptake characteristics of the antibiotic under the conditions used (21, 35, 36, 50) ; the demonstration that changes in ribosome patterns are due to the in vivo treatment, rather than conditions of harvesting and preparation (which are known to affect ribosomes; 16, 17, 37) ; and the specificity of the effects on ribosome patterns as compared to those patterns when growth or protein synthesis are inhibited by other means (32, 38, 39, 52, 57) .
So far, most observations on the in vivo effects of streptomycin and dihydrostreptomycin and their interpretation have failed to take into account any or all of these points. In vitro studies, on the other hand, have been difficult to interpret because of unphysiological conditions used, especially with regard to drug concentrations per ribosome (14, 21, 36) and the known nonspecific interaction of streptomycin and dihydrostreptomycin with nucleic acids (4, 47) .
We now present data on changes in ribosome patterns and distribution, in relation to growth inhibition, which are due to in vivo treatment of susceptible Escherichia coli cultures with dihydrostreptomycin. On the basis of these results, we suggest a mechanism by which this antibiotic inhibits protein synthesis in vivo. 342 KOGUT AND PRIZANT from A. Herzog (24) and maintained on nutrient agar slopes. For experiments, it was grown on mineral salts medium (33, 34) with 0.2% (wt/vol) glucose and 0.2% (wt/vol) Casamino Acids in a shaking water bath to ensure aerobiosis (34) . The methods of measuring culture growth, by absorbance at 500 nm, treatment with dihydrostreptomycin, and determination of its effects on growth rates, by removing extracellular antibiotic at various times, was as previously described (33, 34, 35, 36) . It had been shown in earlier studies that the relationship between absorbance at 500 nm and bacterial dry weight and numbers remained constant during growth-inhibitory action of dihydrostreptomycin (20, 34, 35 (16) . The lysates were centrifuged at 50,000 rpm in the SW50 rotor of a Beckman Spinco L2 centrifuge at 5 C through a 4.0-ml, linear, 15 to 30% (wt/vol) sucrose gradient above a 0.5-ml 50% sucrose cushion, all in medium containing 10 mM tris(hydroxymethyl)aminomethane-hydrochloride buffer (pH 7.3), 60 mM KCl, and either 10 or 2 mM MgSO4 as indicated. Gradients were fractionated by piercing the bottom of each tube and collecting six-drop fractions in two parallel sets of tubes. The middle iwo drops of each fraction were taken for measurement of absorbance at 260 nm in a Unicam spectrophotometer (model SP 500); the other four drops were treated in the cold with 10% (wt/vol) trichloroacetic acid, after addition of 200 ,ug of carrier RNA per fraction, and precipitates then were washed twice with 5% trichloroacetic acid and air dried. Their radioactivities were counted in a Nuclear-Chicago end-window gasflow counter. The figures for absorbance at 260 nm (corrected for dilution) and counts per minute per fraction, for each sample, were plotted against milliliters of gradient to display the patterns of ribosome distribution for control and treated cultures, harvested, lysed, and processed together. For quantitative evaluation of the difference in ribosome patterns between control and treated cultures, the areas under the various peaks were measured with a planimeter (Allbrit, model 01546) and the figures were normalized to a common total area. Because of inherent uncertainties in this method of quantitation (for example, the precise projection of peaks on to the base line for measurement, as well as overlap between peaks), we determined by repeated measurements on the same sample that for the larger peaks, i.e., where the area was above 0.180, as well as for the smaller peaks, the standard deviation from the mean was the same. Hence, the reproducibility was within ±2% for the larger peaks, but only within 46% for the smaller peaks. Computation of the effects of in vivo treatment as the difference between control and treated patterns will therefore tend to be least reliable in the case of the free 50S and 30S subunits, because these values are always small in the controls, and sometimes relatively large in the treated cultures.
Dihydrostreptomycin sulphate was a gift from (32, 34, 35, 36, 37) , we have tried to satisfy the four conditions enumerated in the introduction in the following way.
(i) Measurement of growth rates, calculated from logarithmic increases in absorbance at 500 nm, was chosen as the overall physiological parameter to which specific effects on ribosome pattems have to be related. It was recently shown that under similar conditions incorporation of "4C-labeled amino acids into cold trichloroacetic acid-precipitable material parallels absorbance at 500 nm (25, 26) .
(ii) The conditions for in vivo treatments were such as to give low rates of intracellular accumulation of dihydrostreptomycin and growth inhibition, and hence proportionality between these as described in earlier publications (33, 36) .
(iii) With the technique of joint harvesting of unlabeled log-phase controls and labeled treated cultures, as described (32, 37) , differences in ribosome patterns between controls (absorbance) and treated cultures (counts per minute) can be assumed to be exclusively due to in vivo treatment and not to artifacts introduced during processing of samples, such as run-off of polysomes (37) . Figure 1 shows a representative experiment which illustrates the effects of in vivo treatment of E. coli C 600 with low concentrations of dihydrostreptomycin for various periods on the growth rates, estimated after removal of extracellular antibiotic (35) , and the ribosome profiles. It can be seen that although polysomes tend to decline and 70S particles accumulate in the treated culture, as has also been described by Luzzatto et al. (41) , these effects do not. appear until growth inhibition has become severe. Thus, in the first two samples inhibition of At the same time, further samples of the treated cultures were freed of extracellular antibiotic by filtration, two washings, and resuspension in antibiotic-free medium, for measurement of residual growth rate. Insets are ribosome profiles of the joint lysates obtained from cultures at the indicated times, after centrifugation for 70 min at 50,000 rpm, in sucrose gradients containing 10 mM Mg2+ as described.
growth rate is quite noticeable, but there is little difference in ribosome profiles between controls and treated cultures. This late onset of changes in ribosome patterns, relative to growth inhibition, appeared to be an effect specific to dihydrostreptomycin; many other conditions can produce decline in polysomes and accumulation of 70S particles (17, 32, 38, 39, 52, 59) . It therefore seemed potentially relevant to an understanding of the mechanism by which this antibiotic brings about cessation of growth and protein synthesis. For this reason we undertook VOL. 7, 1975 I I I I I a more detailed analysis of the decline in polysomes, the accumulation of 70S particles and the fate of the free (native) 50S and 30S subunits, in relation to growth inhibition by dihydrostreptomycin. We made use of the technique described in our earlier paper (37) and recent reports (22, 23, 52, 57) which have shown that ribosomes which appear as 70S particles in 10 mM Mg2+ can be differentiated into run-off on the one hand, and polysome-derived monosomes on the other, by their sedimentation behavior under carefully controlled conditions. The joint lysates of unlabeled controls and uracil-labeled, treated cultures were divided into two portions. One of these was immediately centrifuged for 45 min at 50,000 rpm through a sucrose gradient containing 10 mM Mg2+. The other half was treated for 5 min in the cold with ribonuclease (0.1 ,ug/ml) and then immediatelyS centrifuged for 2 h through a similar sucrose gradient, but containing 2 mM Mg2+. The two gradients for each set of cultures were fractionated in identical manner, measurement of absorbance at 260 nm representing control and measurement of radioactivity-treated culture, for each fraction. 1) The profiles from the 10 mM Mg2+ show: (a) the polysome region; (b) the 70S region which contains both polysome-derived and run-off 70S particles; (c) the native, i.e., free, 50S and 30S subunit region. (2) The profiles from the 2 mM Mg2+ gradients show: (a) the 70S peak, containing polysomes and polysome-derived 70S particles; (b) the 50S and 30S peaks containing both 50S and 30S subunits and the dissociated run-off 70S monomers.
After normalization of all profiles, the areas under these regions were measured and the in vivo distribution of ribosomal components calculated as: (i) total polysomes, including any disrupted polysomes = 2a; (ii) run-off ribosomes = la + lb -2a, also 2b -lc; (iii) free 50S and 30S subunits = lc; (iv) free 50S and 30S subunits + run-off ribosomes = 2b.
The method dictates that la + lb + lc = 2a + 2b, since the profiles are obtained from the same original lysate and the total areas normalized. Furthermore, 2b (estimated directly) should equal (ii) + (iii).
We found that the differences between con- trols (areas under the 260-nm peaks) and treated cultures (areas under the radioactivity peaks) showed (ii) + (iii) to be always equal to, but of opposite sign to the differences in (i), i.e. 2a. In other words, changes in polysomal ribosomes due to in vivo treatment can be quantitatively accounted for by changes in run-off ribosomes and free subunits. In Fig. 3 , the decline in total polysomal ribosomes (i) and the accumulation of run-off ribosomes and free subunits (ii) + (iii) in samples from treated cultures are expressed as percent of their controls and plotted against percent inhibition of growth rate. The plots clearly show that depletion of polysomes (Fig.  3A) and accumulation of run-off 70S plus free 50S and 30S ribosomes (Fig. 3B) brought about by dihydrostreptomycin treatment in vivo is a late effect, relative to growth inhibition. In fact, in a number of cases the changes are insignificant, being within ±6% of controls. Although there was no strict correspondence between percent inhibition of growth and these changes in ribosome patterns, a straight line projected from the origin (zero effect on growth rate, zero effect on ribosomes) through only those experimental points showing the most extreme effects would suggest that at 75% inhibiton of growth rate the maximum effect on ribosome distribution does not exceed 30%.
In further experiments, cultures were subjected to run-off conditions by deprivation of carbon source (glucose) or nitrogen source (39,. 52). This was achieved by rapidly filtering and washing cultures and by resuspending in prewarmed medium lacking either glucose or casamino acids. However, under these conditions, only negligible increases in absorbance at 500 nm were observed and had ceased within about 15 min, after which time the cultures were harvested together with their controls. It was therefore not possible to obtain estimates for ribosome distribution patterns before growth inhibition was complete. The changes at that time, however, were in all cases greater than those observed when growth inhibition was produced by treatment with dihydrostreptomycin.
DISCUSSION
We have pointed out in the introduction that, although diminution of polysomes and accumulation of 70S ribosomes in cultures treated with dihydrostreptomycin (or streptomycin) in vivo has been reported on several occasions (32, 41, 42) , elucidation of the mechanism by which these antibiotics bring about cessation of protein synthesis requires more detailed analysis. Luzzatto et al. (41, 42) interpreted the loss of polysomes and accumulation of particles which sediment at 70S in 10 mM Mg2+ (and are deficient in messenger RNA) as evidence for accumulation of special streptomycin monosomes or stuck initiation complexes. However, similar effects can be observed as a consequence of a number of other conditions which inhibit growth (32, 39, 52) . Furthermore, we have shown in recent work (38, 39) that 70S particles which accumulate at the expense of polysomes when growth is progressively inhibited by dihydrostreptomycin behave as run-off ribosomes in their sedimentation characteristics (52) . Furthermore, all ribosomes present in susceptible cultures of E. coli during treatment with dihydrostreptomycin in vivo can be converted to such run-off ribosomes. These observations suggested that the in vivo action of dihydrostreptomycin on ribosomes must allow some translational movement subsequent to initiation. Similar conclusions were drawn by Modolell and Davis from their in vitro studies (45) .
The main results of the current work are that the in vivo effects of dihydrostreptomycin on ribosomes, namely the decline in polysomes and concomitant accumulation of run-off ribosomes (and free 50S and 30S subunits), occurs late, relative to inhibition of growth and protein synthesis.
Since growth rates, and rates of protein synthesis, under given conditions, are proportional to concentrations of functioning ribosomes (31, 53) , any irreversible inactivation of ribosomes could account for decline in growth rates, but accumulation of such inactivated ribosomes should occur in parallel with changes VOL. 7, 1975 346 KOGUT AND PRIZANT in growth rates. Thus, according to current views of the ribosome cycle (9, 58) , one could predict the sequence of changes in ribosome distribution which would follow blockage at specific points in the cycle. Interference with a dissociation factor (44, 57, 59 ), for instance, should lead to accumulation of 70S monosomes. Such an effect would be equivalent to removing ribosomes from circulation, i.e., irreversible inactivation for protein synthesis, and the accumulation of such inactivated ribosomes should parallel the decline in growth rates. Alternatively, the hypothesis that antibiotic-affected ribosomes would be unable to form initiation complexes, perhaps through interference with the function of initiation factors (12, 44, 56) , might be considered. If this were the case, in vivo accumulation of free dissociated 50S and 30S subunits would be expected or, according to Kaempfer (27) , these might reassociate to 70S run-off ribosomes (1). However, the accumulation of such nonfunctional ribosomes should again parallel inhibition of growth. Furthermore, observations of Lenette and Apirion (40) and of Modolell and Davis (46) have suggested that streptomycin-affected ribosomes can initiate.
We conclude, from the fact that polysome depletion and the accompanying changes in ribosome distribution are observable only when growth inhibition is almost complete, that the intracellular dihydrostreptomycin is inhibitory to overall synthetic processes at a time when antibiotic-affected ribosomes can still undergo several cycles of initiation, translation, and termination. As the most attractive hypothesis for resolution of this paradox, we propose the following, which would take into account most (if not all) the known facts about streptomycin action in vivo: combination of intracellular antibiotic with specific proteins of the 30S ribosomes (3) could lead to faulty alignment or recognition (45) with respect to messenger RNA and perhaps transfer RNA (18, 29) during initiation. There is evidence that these ribosomal proteins are accessible only in the free, dissociated subunit (33, 40) . Ribosomes containing such streptomycin-affected 30S subunits could misread certain amino acid codons (48, 49) as terminator codons, i.e., selective misreading. These ribosomes would then be released, or fall off; they might be able to dissociate and re-initiate to repeat the process. As in the course of the still functioning ribosome cycle, increasing numbers of free 30S subunits became available for combination with intracellular antibiotic (33) , increasing proportions of nonfunctional, shortened peptide chains would be synthesized. Thus, since combination of antibiotic with 30S subunits would be gradual, and only streptomycin-affected ribosomes would be malfunctional (and might translate more slowly), this could result in gradually declining growth rates (proportional to the numbers of affected ribosomes) with at first little observable effect on ribosome distribution patterns. Only at a late stage in growth inhibition, when most polysomes would contain a majority of affected ribosomes, making incomplete peptide chains, would changes in ribosome distribution become apparent. Recent observations (26) that the rate of intracellular protein breakdown increases during early stages of in vivo treatment with dihydrostreptomycin, before any effects on ribosome patterns become apparent, would also fit this interpretation.
This model would meet some of the difficulties in accepting the misreading hypothesis (6, 8, 19, 54) as the primary mechanism by which streptomycin exerts its antibiotic action. Thus, misreading or mistranslation as observed in vitro is not specific to streptomycin but can occur under a variety of conditions (15) and is a property of ribosomal genotypes (18) . In the second place, insertion of wrong amino acids in protein molecules more or less at random does not seem a likely mechanism for the inhibition of net protein synthesis which was observed as one of the earliest in vivo effects of this antibiotic (11, 13) . However, if misreading caused by streptomycin in vivo were selective for certain codons and resulted in premature termination of peptide chains then, according to the frequency of such codons in different cistrons, effects on net protein synthesis and growth might become apparent at an early stage, before effects on the ribosome cycle are observable. This hypothesis on the mechanism of streptomycin action in vivo should be capable of experimental verification.
